Author

I. Siavelis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:DNA methylation· 1

Frequent Co-Authors

X. Cao· 2 shared A. C. Hesla· 1 shared A. J. Helmboldt· 1 shared A. Kittai· 1 shared A. Lenze· 1 shared A. Papakonstantinou· 1 shared A. Zucchetto· 1 shared B. Brinkmann· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

X. Cao

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrative multi-omics analysis reveals molecular subtypes and tumor evolution of synovial sarcoma

Y. Chen, Y. Su, I. R. Leo, I. Siavelis, J. Zeng, X. Cao, P. Tsagkozis, A. C. Hesla, A. Papakonstantinou, X. Liu, W.-K. Huang, M. Ehnman, H. Johansson, Y. Lin, J. Lehtiö, , F. Haglund

This study identifies three molecular subtypes of synovial sarcoma through multi-omics analysis, linking BAF complex alterations to tumor evolution and clinical outcomes.

bioRxiv · May 9, 2022 · PreprintCancer Biology

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

S. A. Herbst, M. Vesterlund, A. J. Helmboldt, R. Jafari, I. Siavelis, M. Stahl, E. Schitter, N. Liebers, B. Brinkmann, F. Czernilofsky, T. Roider, P.-M. Bruch, M. Iskar, A. Kittai, Y. Huang, , Hu

The paper performs a proteogenomic analysis of chronic lymphocytic leukemia, identifies a new poor-prognosis subgroup (ASB-CLL) through proteomic profiling, and links it to clinical outcomes.

bioRxiv · Mar 1, 2022Cancer Biology